improving care in a learning health care system
DESCRIPTION
Improving Care in a Learning Health Care System. Richard B. Colletti , MD Vice Chair for Clinical and Research Affairs. Overview. Reliability in health care Application of the Model for Improvement to pediatric IBD ImproveCareNow - PowerPoint PPT PresentationTRANSCRIPT
Improving Care in a Learning Health Care System
Richard B. Colletti, MDVice Chair for Clinical and Research Affairs
2
Overview
Reliability in health careApplication of the Model for Improvement to pediatric IBDImproveCareNow
Improving care and outcomes for children with Crohn’s disease and ulcerative colitisCollaborative Chronic Care Network (C3N)Learning Health Care System
How I did I get to Vancouver?
What was the probability…
that my plane would crash?1 in 1,000,000 (failure rate)Reliability rate: 99.9999%that my bag would not arrive?1 in 100 (failure rate)Reliability rate: 99%that my plane would arrive late?1 in 10 or worse (failure rate)Reliability rate: 90%
4
5
What is the reliability of medical care?
Patients receive only 60% of recommended carePatients take only 60% of recommended medicationsThere is a gap between recommended care and the care actually carried outIf medical care and patient self-management were more reliable, would outcomes be better?
5
Remission rate
7
Centers with >75% enrolled % of patients by disease status
77%
18%
5%
••Inactive•• ••Mild•• ••Moderate-Severe••
8
How we improve care and outcomes
1. Establish Aims and MeasuresWhat are we trying to accomplish?How would we know if a change is an improvement?
2. Measure performance 3. Identify gaps between standard and actual
performance4. Make changes to close the gaps using tools to
increase reliability
Practice Guideline
46 Pediatric GI Centers
9
10
14,200 IBD patients46 centers
425 Ped GI
30%
How many patients in the registry?
11
45,000 visits
8,700 enrolled
Largest and fastestgrowing in the world
A gold mine of datafor learning
Data collection and entry
Enroll every patient with inflammatory bowel disease
Enter data for every outpatient visit
50 to 75 data elements each visitManual web-based data entry into registry
12
9 process measures: Classification bundle
13
5 classifications: disease severity, extent, phenotype; nutrition & growth
14
6 outcome measures:Remission rate
2007 2008 2009 2010 2011
R.Colletti 2009
12. Growth status is classified(100%, 90%, n=29)
Number of patients
enrolled in Clinipace
(cumulative)
17. Appropriate doses of Sulfasalazine and/or
Mesalamine(83%, 85%, n=6)
18. Started on a 6MP or azathioprine
. . . pre-tested for TPMT level(100%, 90%, n=3)
11. Satisfactory growth status(99%, 88%, n=89)
3. Disease severity is documented
(100%, 90%, n=29)
6. Nutritional status is classified(100%, 90%, n=29)
2. Disease phenotype and extent of disease are documented
(100%, 90%, n=29)
4. Height, weight and BMI are plotted
(96%, 90%, n=25)
5. Satisfactory nutritional status (97%, 89%, n=89)
1. Complete diagnostic and initial evaluation
(100%, 90%, n=1)
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0
20
40
60
80
100
04
/07
06
/07
08
/07
10
/07
12
/07
02
/08
04
/08
06
/08
08
/08
10
/08
*
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
Plan
DoStudy
Act
Patient visit
Data collection
Data entry
Data storage
Data analysis
Reportsto sites
Reportanalysis
Plan and carry outchanges
16
March 2012
Netw ork Target
> 75% Pts. Enrolled Teams'
Performance
Team's 90-Day Goal
Team's Performance March 2012
1. Remission Rate 80% 76% 78%
2. Steroid free remission rate 76% 73% 77%
3. Sustained remission rate 45% 56% 64%
4. % of patients off prednisone 95% 92% 92%
5. % of patients w ith satisfactory nutritional status 90% 90% 95%
6. % of patients w ith satisfactory grow th status 90% 90% 93%
7. % of patient visits w ith complete classif ication bundle 95% 95% 100%
8. % of patients w ith a documented visit w ithin the last 6 months 80% 76% 72%
9.% of visits starting treatment w ith a thiopurine w ho have had measurement of TPMT (3-month moving average)
90% 78% 100%
10. % of patients w ith thiopurine dose prescribed according to Model Care 80% 78% 63%
11.% of visits at w hich 6-TGN level is measured according to Model Care (3-month moving average)
75% 40% 100%
12.% of visits at w hich patient had initiation dose of inf liximab and had prior PPD or chest X-ray (3-month moving average)
95% 73% 0%
13. % of patients w here the dose of inf liximab is given according to Model Care 95% 96% 100%
14.% of visits w here the inf liximab trough level of patients treated w ith inf liximab is measured according to Model Care (3-month moving average)
75% 54% 100%
15.% of patients treated w ith methotrexate w here the dose is at least 10 mg/square-meter per w eek
95% 90% 100%
The mission of the ImproveCareNow Network is to develop and test specific changes that will lead to improvement in the care of children with pediatric IBD and determine how best to incorporate these improvements into everyday practice.
Key Measure
Clinical Remission
Adequate Nutrition and Growth
Model Classification
Key Measures
Vermont Childrens Hospital
Model Treatment
MONTHLY KEY MEASURES REPORT
17
10. Thiopurine dose according to Model Care
(75%, 80%, n=509)
3. Sustained remission rate
(57%, 45%, n=1352)
1. Remission rate(76%, 80%, n=2435)
Key MeasuresMonthly Report – December 2011
Advanced TrackAll Sites Performance
8. Documented visit in last 6 months
(79%, 80%, n=3031)
2. Steroid free remission rate
(72%, 76%, n=2424)
9. Starting thiopurine and TPMT measured
(67%, 90%, n=6)
(score, goal, n)
7.Complete documentation bundle
(94%, 95%, n=502)
15.Methotrexate dose >= 10 mg/square-meter/w eek
(91%, 95%, n=65)
14. Inf liximab trough level measured
(55%, 75%, n=11)
6. Satisfactory grow th status
(93%, 90%, n=1851)
13. Inf liximab dose according to Model Care
(95%, 95%, n=535)
4. Off prednisone(91%, 95%, n=2542)
11. 6-TGN level measured according to Model Care
(17%, 75%, n=12)
5. Satisfactory nutritional status
(90%, 90%, n=2615)
12. Inf liximab initiation and prior PPD or chest X-ray
3-month moving average(79%, 95%, n=34)
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
04/0
708
/07
12/0
704
/08
08/0
812
/08
04/0
908
/09
12/0
904
/10
08/1
012
/10
04/1
108
/11
12/1
1
75%80%85%90%95%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
0%20%40%60%80%
100%
75%80%85%90%95%
100%
0%20%40%60%80%
100%
04/0
708
/07
12/0
704
/08
08/0
812
/08
04/0
908
/09
12/0
904
/10
08/1
012
/10
04/1
108
/11
12/1
1
MONTHLY KEY MEASURES REPORT
18Control charts and Exceptions Report
MONTHLY DATA QUALITY REPORT
March 2012
Netw ork's Performance
Center's Performance
Netw ork Target
1. Proportion of population enrolled AND active in registry
2. Proportion of patients enrolled w ithin 90 days of diagnosis 36% 80%
3. Proportion of actual visits recorded in registry 85%
4. Proportion of visits w ith all critical data recorded 89% 91% 95%
5. Proportion of visits w ith height, w eight, and BMI Z-scores betw een -3 and +3 96% 94% 99%
6.Proportion of visits w here PGA is w ithin 1 category of appropriate activity index 96% 100% 95%
7. Proportion of visits w here height is no more than 1 cm below prior value 94% 96% 99%
8. Proportion of visits w ithout an impossible change in phenotype/extent 92% 91%
9. Proportion of visits entered w ithin 30 days of visit date *** 84% 100% 90%
10. Proportion of active patients in registry w ith visit recorded in last 13 months 95% 84%
Data Monthly Report
Key Measure
Data Quality Measures
Communicate & Collaborate
R.Colletti 2004 19
2007
Communications
ListservImproveCareNow Portal (on-line resource center)www.ImproveCareNow.orgWeekly DigesteNewsletter: CircleBlog: LoopeNewsletter for practitioners: ScopeFacebook, Twitter, YouTube
20
Interventions
Registry enrollment and data qualityModel IBD Care guidelinePopulation management
Care stratification
Pre-visit planningSelf-management support
21
Vermont Childrens1/17/2012
Patients by Diagnosis Patients by RacePrimary Provider (All) Primary Provider (All)
Data DataDX #Patients % Patients Race #Patients % PatientsCrohn's 62 70% White 74 84%UC 24 27% AfricanAmerican 1 1%IndColitis 2 2% Unknown 13 15%(blank) 0% (blank) 0%Grand Total 88 100% Grand Total 88 100%
Patients by Age Group Primary Provider (All) Primary Provider (All)Primary Provider (All)
DX Data DX DataData Crohn's UC
Age Group #Patients % Patients Age Group #Patients % Patients Age Group #Patients % Patients6-10 2 2% 6-10 1 2% 6-10 1 4%11-14 17 19% 11-14 13 21% 11-14 2 8%15-17 30 34% 15-17 19 31% 15-17 11 46%>17 39 44% >17 29 47% >17 10 42%(blank) 0% Grand Total 62 100% Grand Total 24 100%Grand Total 88 100%
Patients by Gender Primary Provider (All) Primary Provider (All)Primary Provider (All)
DX Data DX DataData Crohn's UC
Gen #Patients % Patients Gen #Patients % Patients Gen #Patients % PatientsF 46 52% F 30 48% F 15 63%M 42 48% M 32 52% M 9 38%(blank) 0% Grand Total 62 100% Grand Total 24 100%Grand Total 88 100%
Population Management Report as of:
TWICE-MONTHLY POPULATION MANAGEMENT REPORT
23
TWICE-MONTHLY POPULATION MANAGEMENT REPORT
24
Population management: care stratification
25
Risk Name Score Overall Score
PGA-Moderate MK 3 6Prednisone MK 3 6PGA-Moderate WB 3 6Nutrition-Failure WB 3 6PGA-Mild WJ 1 5Prednisone WJ 3 5Growth-At Risk WJ 1 5PGA-Mild WV 1 5Nutrition-At Risk WV 1 5Growth-Failure WV 3 5PGA-Mild DM 1 4Prednisone DM 3 4Prednisone LA 3 4Nutrition-At Risk LA 1 4PGA-Moderate BS 3 3Growth-Failure NA 3 3Prednisone VS 3 3PGA-Mild BB 1 1PGA-Mild MB 1 1PGA-Mild MD 1 1PGA-Mild PM 1 1PGA-Mild RJ 1 1PGA-Mild TE 1 1
COMING SOON: AUTOMATED POPULATION MANAGEMENT & CARE STRATIFICATION
PRE-VISIT PLANNING
28
COMING SOON: AUTOMATED PRE-VISIT PLANNING
ImproveCareNow Current State: Data Recorded Three Times
Encounter Abstraction Data Entry
29
ImproveCareNow Coming Soon:Data-in-Once, Files Uploaded
Structured data is extracted
from the EHR
Data is uploaded to the
ImproveCareNow database
AnalysisQI
CER
Encounter
30
C3N Project Collaborative Chronic Care Networks
NIH TR01 grantTransform ImproveCareNow into a C3N
Join patients, parents, clinicians and researchers in a shared collaborative networkImprove clinical practice, patient self-management, and disease outcomes
Innovative prototypesYouMeIBD.com, Passive PRO app, mentoring program, N of 1 Trials with PRO app, Peer Produced Practice Knowledge, mobile social gamesPatient Advisory Council, Parent Working Group, Building Community Leadership, patient platform: create a patient- and family-centered network
32
Learning Healthcare System
“Designed to generate and apply the best evidence for the collaborative choices of each patient and provider; to drive the process of discovery as a natural outgrowth of patient care; and to ensure innovation, quality, safety, and value in health care”
Learning Health Care System
1. Community2. Focus on the outcome3. Data-in-once4. Quality improvement5. Comparative effectiveness6. Governance
34
Using data for research as well as QI: Simulated trial
35
Outcomes ImproveCareNow n=96; REACH n=112
NS
NS
Simulated trial with control group
36
The value equation
37
Value = outcomes cost
Purpose of ImproveCareNow
Transform the health, care and costs for all children and adolescents with Crohn’s disease and ulcerative colitis by building a sustainable collaborative chronic care network, enabling patients, families, clinicians and researchers to work together in a learning health care system to accelerate innovation, discovery and the application of new knowledge.
38
September 2012
https://improvecarenow.org/joinus